ALPHA TRIBE

Lincoln Pharmaceuticals LimitedBoard Meeting, 12-02-2026: Outcome of Board Meeting

12-02-2026 | 11:30 am

Lincoln Pharma's board approved Q3 FY26 consolidated results: Net Profit surged 37.70% to Rs 28.60 Cr, revenue up 13.49% to Rs 166.32 Cr. The company targets Rs 1,000 Cr revenue in 3 years with 15-18% annual growth, expanding globally.

No comments yet. Be the first to comment!

All announcements from Lincoln Pharmaceuticals Limited